Groowe Groowe / Newsroom / ONCY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ONCY News

Oncolytics Biotech, Inc. Common Shares

Oncolytics Biotech® Reports Updated Anal Cancer Data Showing Objective Response Rate More Than Double the Current Standard of Care

prnewswire.com
ONCY

Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study

prnewswire.com
ONCY

Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals

prnewswire.com
ONCY ANIX ICCM IBRX REGN ONCY ANIX ICCM IBRX REGN

Oncolytics Biotech® Provides Update on GOBLET Study Progress and U.S. Site Expansion

prnewswire.com
ONCY

Breakthrough Therapy Designations Surge as $50B Cancer Drug Partnerships Reshape Market

prnewswire.com
ONCY HCM CGON CCCC IDYA ONCY HCM CGON CCCC IDYA

Oncolytics Biotech® Highlights Strong Efficacy and Translational Data in Metastatic Colorectal Cancer; Will Advance Regulatory Pathway Discussions

prnewswire.com
ONCY